Shionogi & Co Ltd

JP

SHNGI

Health Care

11.73 ₽

Current price

Buy
11.73 ₽

Target price 00%

Ranks rating

76

  • Position in sub-industry

    458 / 1328

  • Position in country

    2906 / 4811

  • Return on Assets, %

    11.3

    -2.7

  • Net income margin, %

    34

    2.8

  • EBITDA margin, %

    42.5

    10.8

  • Debt to Equity, %

    0.8

    19.2

  • Intangible assets and goodwill, %

    9.7

    3.6

  • Revenue CAGR 3Y, %

    8.5

    8.5

  • Total Equity change 1Y, %

    5

    0

  • Revenue Y, % chg

    -13.6

    0.5

  • P/E

    13.8

    22.7

  • P/BV

    1.7

    1.5

  • P/S

    5.3

    2.3

  • EV/S

    4.1

    2.4

  • EV/EBITDA

    11.1

    7.4

  • Average Analyst recommendation

    Hold

    Hold

  • Average upside forecasts, %

    353.5

    51.3

  • Forward P/E

    14.4

    15.6

  • Dividend Yield, %

    2.1

    1.7

  • Forward Dividend Yield, %

    8.7

    0.2

  • Expected dividend per share

    1

    0

  • Payout Ratio, %

    28.7

    30.3

Get an analytical review of this company

Competitors

Ranks

  • Daiichi Sankyo Co Ltd

    00%

  • Ono Pharmaceutical Co Ltd

    00%

  • Kyowa Kirin Co Ltd

    00%

  • Shionogi & Co Ltd

    00%

  • Taisho Pharmaceutical Holdings Co Ltd

    00%

  • Chugai Pharmaceutical Co Ltd

    00%

  • Takeda Pharmaceutical Co Ltd

    00%

  • Eisai Co Ltd

    00%

  • Otsuka Holdings Co Ltd

    00%

  • Astellas Pharma Inc

    00%

Ready-made portfolio of the best Russian stocks

  • Created by artificial intelligence
  • Verified by analysts
  • Available even to beginners

Company information

  • Country

    Japan

  • Sector

    Health Care

  • Industry group

    Pharmaceuticals, Biotechnology & Life Sciences

  • Industry

    Pharmaceuticals

  • Sub-sector

    Health Care

  • Capitalization (millions of $)

    14712.5

  • Ticker

    SGIOY.PK

  • ISIN

    US8246671098

  • IPO date

    1949-05-16

  • Availability on Russian exchanges

    No

  • Reporting for

    2024-02-09

  • Date fact. publication of reports

    2023-12-31

Company Description

Shionogi & Co., Ltd. is a Japan-based pharmaceutical company mainly engaged in the research, development, purchase, manufacture and sale of pharmaceuticals, as well as pharmaceutical-related businesses. The prescription drug business is engaged in the development of eight new drugs including hypercholesterolemia treatment drugs Crestor, antihypertensive drugs Ilbetan Family (Irbetan, Aimix, Iltra) and antidepressant drugs Sinbalta. The Company is engaged in the provision of information to contribute to medical care by maximizing its products. The over-the-counter (OTC) pharmaceutical business handles products tailored to customers' lifestyles. The in-vitro diagnostics business is engaged in the sale of products, as well as the provision of information on infectious diseases, cardiovascular diseases and allergic diseases. The Company mainly provides its products and services in Japan, Europe and North America markets.

A step towards better analytics

  • find the best promotions through the Screener
  • keep an eye on stock valuation
  • download detailed reports

and much more after free registration

Registration

More convenient from your phone? Download: